Homoeopathic research into home isolation cases flu, or covid.

 Italian society of homeopathy

The initiative of SIMO – Italian Society of Homeopathic Medicine (www.omeomed.net),

The level of hospitalization is one of the key factors in assessing the ability of the health care system to respond to the epidemic. The recent ECDC report states: “Hospitalization occurred in 32% (48,755 of 152,375) of cases reported from 26 countries”

In Italy, the bulletin on the Covid-19 epidemic of March 30, 2020 produced by the Istituto Superiore di Sanità writes: “Information on the place of treatment is available for 88,257 cases (about 70.8% of total cases). Currently 18,047 cases (20.4%) are hospitalized and of these 2,734 (18.7%) are hospitalized in intensive care”.(10)

Therefore, the purpose of this study was to evaluate the level of hospitalization of Covid-19 patients treated by doctors with additional expertise in homeopathy.

From 25 February to 7 April 2020 we collected 50 symptomatic case reports in home isolation, positive or probable COVID-19, followed by the family doctor and, since the patients requested it, also by a physician expert in homeopathy. The patients were in isolation in different Italian locations.

The classification to which this study adheres is the WHO classification which is the basis of the classifications of the various Ministries of Health. In order to try to increase diagnostic accuracy we have chosen to qualitatively implement the WHO guidelines with clinical and anamnestic parameters (see below).

The clinical records we considered includes 10 confirmed symptomatic patients for COVID-19 and 40 probable symptomatic patients semasiologically similar to the previous ones.

A total of 24 homeopaths were involved. They are clinicians with extensive experience in homeopathy and are all registered in the lists of homeopathic medical experts with the respective Orders of Physicians and Surgeons.

Each doctor involved in the project was required to send all consecutive cases under treatment, whatever the outcome of the treatment implemented.

RESULTS

The 50 cases examined consisted of 29 females and 20 males, (in one gender not specified), all between 6 and 79 years old. Duration of treatment was varying from 4 to 34 days.

In the 4 pediatric cases (years 6-9), the average age was 6.75 years; their course lasted on average10 days (from 3 to 17).

In each individual case only one single-component homeopathic medicinal product has been diagnosed and prescribed at a time with only one potency, chosen individually according to the symptoms presented.

No adverse events were observed during homeopathic treatments. An overall recovery of patients at resolution of specific symptoms has been commonly observed.

All patients were symptomatic and classified as COVID positive or highly probable; they were all treated homeopathically in extra-hospital home isolation regimen. Under no circumstances, given the favorable clinical trend, was hospitalization necessary.

The hospitalization rate in this group of 50 patients treated homeopathically for COVID-19 was 0.

 You can google Italian Society of Homeopathic Medicine (www.omeomed.net),  for a copy of the study.